OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PET imaging of new target CDK19 in prostate cancer
Dong Dai, Yu Jiang, Ting Huang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 11, pp. 3452-3464
Closed Access | Times Cited: 8
Dong Dai, Yu Jiang, Ting Huang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 11, pp. 3452-3464
Closed Access | Times Cited: 8
Showing 8 citing articles:
Mediator kinase inhibition reverses castration resistance of advanced prostate cancer
Jing Li, Thomas A. Hilimire, Yueying Liu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 10
Open Access | Times Cited: 13
Jing Li, Thomas A. Hilimire, Yueying Liu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 10
Open Access | Times Cited: 13
Synthesis and Imaging of Novel CDK19‐Targeted Tracers Incorporating an Albumin‐Binding Moiety
Panfeng Li, Zhao Yang, Yanli Li, et al.
Journal of Labelled Compounds and Radiopharmaceuticals (2025) Vol. 68, Iss. 3
Closed Access
Panfeng Li, Zhao Yang, Yanli Li, et al.
Journal of Labelled Compounds and Radiopharmaceuticals (2025) Vol. 68, Iss. 3
Closed Access
Novel CDK19-Targeted Radiotracers: A Potential Design Strategy to Improve the Pharmacokinetics and Tumor Uptake
Dong Dai, Yu Jiang, Wenfeng Gou, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6726-6737
Closed Access | Times Cited: 3
Dong Dai, Yu Jiang, Wenfeng Gou, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6726-6737
Closed Access | Times Cited: 3
CD13 as a potential theranostic target for prostate-specific membrane antigen-negative prostate cancer and first-in-human study of [18F]AlF-CD13-L1 PET/CT imaging
Wei Tang, Ming Zhou, Chenxi Lu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Wei Tang, Ming Zhou, Chenxi Lu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Walter Filgueira de Azevedo, Rodrigo Quiroga, Marcos A. Villarreal, et al.
Journal of Computational Chemistry (2024) Vol. 45, Iss. 27, pp. 2333-2346
Closed Access | Times Cited: 2
Recent Advances in Radiotracers Targeting Novel Cancer-Specific Biomarkers in China: A Brief Overview
Jingming Zhang, Fei Kang, Xiao Wang, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. Supplement 1, pp. 38S-45S
Closed Access | Times Cited: 1
Jingming Zhang, Fei Kang, Xiao Wang, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. Supplement 1, pp. 38S-45S
Closed Access | Times Cited: 1
CDK19 and CDK8 Mediator kinases drive androgen-independentin vivogrowth of castration-resistant prostate cancer
Jing Li, Thomas A. Hilimire, Yueying Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Jing Li, Thomas A. Hilimire, Yueying Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Les radiotraceurs autres que le PSMA-ligand pour l’imagerie TEP du cancer de prostate
Nadia Withofs, R. Hustinx, Clément Morgat
Médecine Nucléaire (2023) Vol. 47, Iss. 5, pp. 281-290
Open Access
Nadia Withofs, R. Hustinx, Clément Morgat
Médecine Nucléaire (2023) Vol. 47, Iss. 5, pp. 281-290
Open Access
